Monday, November 16, 2026
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEANFastest Growing
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEANFastest Growing
Fiinews
No Result
View All Result
Home Health

Rubicon develops global network with Canadian acquisition

Fiinews by Fiinews
January 10, 2020
in Health, Industry Sectors, Investment, Manufacturing, Projects
Reading Time: 2 mins read
A A
0
India INX
0
SHARES
12
VIEWS
LinkedinShare on Twitter

Rubicon-Impopharma plan new projects

 

Rubicon Research

As part of its ongoing effort to establish a global development network, Rubicon Research Private Limited is planning new projects with new acquisition Impopharma Canada Limited.

Over the next several months, the Company plans to establish development plans for a mix of both internal and external development projects, said Rubicon on 7 Jan 2020.

“I welcome the Impopharma team to the Rubicon Research family and look forward to building new projects and capabilities together,” said Parag Sancheti, Rubicon’s Chief Executive Officer.

Impopharma offers comprehensive drug product formulation and process development, as well as wide-ranging analytical testing services to the pharmaceutical industry, specializing in nasal and pulmonary drug products.

The 13,000 sq. ft. Impopharma site in Concord, near Toronto, has been previously inspected by the U.S. FDA and Health Canada and will be the nasal and pulmonary development Center of Excellence in the Rubicon network.

Impopharma Canada has been merged with Rubicon Research Canada Limited, a wholly owned subsidiary of Rubicon Research Private Limited.

Rubicon is a responsible partner to global healthcare innovators that design and deliver quality products for making patients’ lives healthy and happy. Rubicon also develops and commercializes its own value-added formulations in the global market.

Rubicon currently has several commercial products in the global market and a pipeline of over 60 products in development or under review.

Rubicon holds more than 50 issued patents in drug delivery technologies and with its new R&D center can develop pharmaceutical products across dosage forms.

The manufacturing facility located in Ambernath (India) has global regulatory approvals for commercial supply of oral solid dosage forms.

Rubicon also has a marketing office based in New Jersey. fiinews.com

ShareTweetShare

Related Posts

MRPL
Projects

Project: PM dedicates Bengaluru terminal to nation

by Fiinews
November 16, 2026
0
20

Terminal has dedicated ethanol and biodiesel storage and blending infrastructure Prime Minister Narendra Modi has dedicated to the nation Mangalore...

ISNT
Manufacturing

Manufacture: Minister wants a strengthened NDT ecosystem

by Fiinews
November 16, 2026
0
17

Public Sector Undertakings, private manufacturers, start-ups and MSMEs have important role to play defence technology Defence Minister Rajnath Singh has...

Singapore Exchange

Invest: UTI Nifty listed in Singapore

November 14, 2026
19
NITI Aayog

Manufacture: PLI successful, says NITI Aayog

November 14, 2026
16
Zetsol

Manufacture: 22 bids received for ACC facilities

November 14, 2026
21
Cochin Shipyard

Project: INS Betwa to be re-powered

November 13, 2026
19
SBI YONO

Recent News

  • Market: Hanon reinforced commitment to India
  • Project: PM dedicates Bengaluru terminal to nation
  • Manufacture: Minister wants a strengthened NDT ecosystem
  • Tech: Joshi’s call “think beyond boundaries”
  • Market: Drone industry set to grow to Rs.97,300cr

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY
  • About
  • Advertise
  • Careers
  • Contact us

© 2026 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEAN

© 2026 FIINEWS - Design and developed by 7clicksmedia.